A Pilot Trial of Adjunctive Gabapentin in the Treatment of Bipolar Disorder
Tóm tắt
Several antiepileptic drugs (AEDs) have documented efficacy in the manic phase of bipolar disorder. To investigate the efficacy, tolerability, and safety of the new AED, gabapentin, in mania, we treated nine consecutive outpatients with bipolar I or II disorder by DSM-IV criteria who were experiencing hypomanic, manic, or mixed states inadequately responsive to standard mood stabilizers with open-label, adjunctive gabapentin. Response of manic symptoms was assessed monthly as none, minimal, moderate, or marked. Of the nine patients, seven displayed a moderate or marked reduction in manic symptoms by 1 month after addition of gabapentin, and an additional patient displayed moderate improvement after 3 months. Of these eight patients, six displayed continued antimanic responses for follow-up periods ranging from 1 to 7 months. Side effects were most commonly neurological, mild, and transient. Adjunctive gabapentin may have antimanic and mood-stabilizing effects in some patients with bipolar disorder and is generally well tolerated. Controlled studies of gabapentin in bipolar disorder appear to be warranted.
Tài liệu tham khảo
American Psychiatric Association: Work Group on Bipolar Disorder. Practice Guideline for the Treatment of Patients with Bipolar Disorder. Am J Psychiatry 1994;151(Suppl):i–36
Bowden C: Treatment of bipolar disorder. In: Nemeroff CB, Schatzberg AS, eds. Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995: 603–614
Calabrese JR, Bowden CB, Woyshville MJ: Lithium and anticonvulsants in the treatment of bipolar disorder. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:1099–1111
McElroy SL, Keck PE Jr: Drugs for treatment of bipolar disorder: Anticonvulsants. In: Nemeroff CB, Schatzberg AS (eds): Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press, 1995:351–356
UK Gabapentin Study Group: Gabapentin in partial epilepsy. Lancet 1990; 335:1114–1117
Bruin J, Sanders M, Anhut H, et al.: Efficacy and safety of gabapentin (Neurontin): A multicenter, placebo-controlled, double-blind study. Neurology 1991; 41(Suppl 1):330–331
U.S. Gabapentin Study Group No. 5: Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel group study. Neurology 1993; 43:2292–2298
Browne TR (for the International, U.K., and U.S. Gabapentin Study Groups): Efficacy and safety of gabapentin. In: Chadwick, D, ed. New Trends in Epilepsy Management: The Role of Gabapentin. Royal Society of Medicine Services International Congress and Symposium Series, No. 198. London: Royal Society of Medicine Services, 1993:47–57
Chadwick D: Gabapentin. Clinical use. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York: Raven Press, 1995:851–856
Taylor CP: Gabapentin. Mechanism of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York, Raven Press, 1995:829–841
McLean MJ: Gabapentin. Chemistry, absorption, distribution, and excretion. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York: Raven Press, 1995:843–849
Ramsay RE: Gabapentin. Toxicity. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York: Raven Press; 1995: 57–860
Ryback R, Ryback L: Gabapentin for behavioral dyscontrol (letter). Am J Psychiatry 1995; 152:1399
Stanton SP, Keck PE Jr, McElroy SL: Treatment of acute mania with gabapentin (letter). Am J Psychiatry 1997; 154:287
Schaffer CB, Schaffer LC: Gabapentin in the treatment of bipolar disorder (letter). Am J Psychiatry 1997; 154:291–292
Bennett J, Goldman WT, Suppes T: Gabapentin for treatment of bipolar and schizoaffective disorders (letter). J Clin Psychopharmacol 1997; 17:141–142
McElroy SL, Pope HG Jr, Keck PE Jr, et al.: Are impulse control disorders related to bipolar disorder? Comp Psychiatry 1996; 37:229–240
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994
Wolf SM, Shinnar S, Kang H, et al.: Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1995; 36:1203–1205
Lee DO, Steingard RJ, Cesena M, et al.: Behavioral side effects of gabapentin in children. Epilepsia 1996; 37:87–90
Short C, Cooke L: Hypomania induced by gabapentin. Br J Psychiatry 1995; 166:679–680